Evidence map›Paper›PMID 39755720›Full record

ArticleNPJ Parkinson's disease2025

Park7 deletion leads to sex-specific transcriptome changes involving NRF2-CYP1B1 axis in mouse midbrain astrocytes.

Sergio Helgueta, Tony Heurtaux, Alessia Sciortino, Yujuan Gui, Jochen Ohnmacht, Pauline Mencke, Ibrahim Boussaad, Rashi Halder, Pierre Garcia, Rejko Krüger and 4 more

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sergio HelguetaDepartment of Life Sciences and Medicine (DLSM), University of Luxembourg, Belvaux, Luxembourg.ORCID http://orcid.org/0000-0002-4100-2964
Tony HeurtauxDepartment of Life Sciences and Medicine (DLSM), University of Luxembourg, Belvaux, Luxembourg.
Alessia SciortinoLuxembourg Centre of Neuropathology (LCNP), Luxembourg, Luxembourg.
Yujuan GuiDepartment of Life Sciences and Medicine (DLSM), University of Luxembourg, Belvaux, Luxembourg.
Jochen OhnmachtDepartment of Life Sciences and Medicine (DLSM), University of Luxembourg, Belvaux, Luxembourg.ORCID http://orcid.org/0000-0001-7109-6802
Pauline MenckeLuxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg.
Ibrahim BoussaadLuxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg.ORCID http://orcid.org/0000-0002-3512-3364
Rashi HalderLuxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg.
Pierre GarciaLuxembourg Centre of Neuropathology (LCNP), Luxembourg, Luxembourg.ORCID http://orcid.org/0000-0002-6681-9671
Rejko KrügerLuxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg.ORCID http://orcid.org/0000-0003-4258-6241
Michel MittelbronnDepartment of Life Sciences and Medicine (DLSM), University of Luxembourg, Belvaux, Luxembourg.
Manuel ButtiniLuxembourg Centre of Neuropathology (LCNP), Luxembourg, Luxembourg.
Thomas SauterDepartment of Life Sciences and Medicine (DLSM), University of Luxembourg, Belvaux, Luxembourg.
Lasse SinkkonenDepartment of Life Sciences and Medicine (DLSM), University of Luxembourg, Belvaux, Luxembourg. lasse.sinkkonen@uni.lu.ORCID http://orcid.org/0000-0002-4223-3027

Funding

Fonds National de la Recherche Luxembourg (National Research Fund) AFR PhD 12447024Fonds National de la Recherche Luxembourg (National Research Fund) MAMaSynFonds National de la Recherche Luxembourg (National Research Fund) MiRisk [C17/BM/11676395]Fonds National de la Recherche Luxembourg (National Research Fund) MotaSYN [12719684]Fonds National de la Recherche Luxembourg (National Research Fund) NCER-PDFonds National de la Recherche Luxembourg (National Research Fund) P16/BM/11192868Fonds National de la Recherche Luxembourg (National Research Fund) PRIDE 17/12244779/PARK-QC
6 · The paper itself

Abstract

Loss-of-function mutations in PARK7, encoding for DJ-1, can lead to early onset Parkinson's disease (PD). In mice, Park7 deletion leads to dopaminergic deficits during aging, and increased sensitivity to oxidative stress. However, the severity of the reported phenotypes varies. To understand the early molecular changes upon loss of DJ-1, we performed transcriptomic profiling of midbrain sections from young mice. While at 3 months the transcriptomes of both male and female mice were unchanged compared to their wildtype littermates, an extensive deregulation was observed in 8 month-old males. The affected genes are involved in processes like focal adhesion, extracellular matrix interaction, and epithelial-to-mesenchymal transition (EMT), and enriched for primary target genes of NRF2. Consistently, the antioxidant response was altered specifically in the midbrain of male DJ-1 deficient mice. Many of the misregulated genes are known target genes of estrogen and retinoic acid signaling and show sex-specific expression in wildtype mice. Depletion of DJ-1 or NRF2 in male primary astrocytes recapitulated many of the in vivo changes, including downregulation of CYP1B1, an enzyme involved in estrogen and retinoic acid metabolism. Interestingly, knock-down of CYP1B1 led to gene expression changes in focal adhesion and EMT in primary male astrocytes. Finally, male iPSC-derived astrocytes with loss of function mutation in the PARK7 gene also showed changes in the EMT pathway and NRF2 target genes. Taken together, our data indicate that loss of Park7 leads to sex-specific gene expression changes through astrocytic alterations in the NRF2-CYP1B1 axis, suggesting higher sensitivity of males to loss of DJ-1.

Identifiers

PMID39755720
PMCPMC11700157

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.